MANAGEMENT OF ACUTE CORONARY SYNDROMES DURING PREGNANCY: A RETROSPECTIVE ANALYSIS OF PCI INTERVENTIONS IN PAKISTANI HOSPITALS
Main Article Content
Keywords
Acute Coronary Syndromes, Pregnancy, Percutaneous Coronary Intervention, Major Adverse Cardiovascular Events, Pakistan.
Abstract
Background: Acute Coronary Syndromes (ACS) encompass conditions such as unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), characterized by sudden reduced blood flow to the heart. The management of ACS has traditionally relied on medical therapy, thrombolysis, and percutaneous coronary intervention (PCI), with PCI being the preferred strategy due to its efficacy. However, managing ACS during pregnancy presents unique challenges due to physiological changes and the need to balance maternal and fetal safety.
Objective: This study aimed to evaluate the management and in-hospital outcomes of pregnant women with ACS undergoing PCI in Pakistani hospitals.
Methods: A retrospective analysis was conducted on pregnant women aged 18-45 years diagnosed with ACS who underwent PCI across multiple Pakistani hospitals from January 2018 to December 2022. The study excluded patients with prior coronary artery bypass grafting, terminal non-cardiovascular illnesses, or those who did not consent. Data were collected from medical records and analyzed using SPSS version 25.0. The primary outcomes assessed were the incidence of Major Adverse Cardiovascular Events (MACE) during hospitalization, including myocardial infarction (MI), target vessel revascularization (TVR), and cardiovascular death. Secondary outcomes included left ventricular ejection fraction (LVEF) post-PCI, hospital length of stay, and complications such as bleeding and stroke.
Results: The study included 300 pregnant women with ACS undergoing PCI. The mean age of the patients was 32.4 years (SD: 4.5 years). The overall incidence of MACE was 18.7%, with 7.3% experiencing MI, 6.0% undergoing TVR, and 5.3% resulting in cardiovascular death. The mean LVEF post-PCI was 50.2% (SD: 9.8%), and the median hospital stay was 6 days (IQR: 4-9 days). Significant differences in primary outcomes were observed between hypertensive and non-hypertensive patients, with hypertensive patients showing higher incidences of MACE (33.3% vs. 12.4%, p<0.001).
Conclusion: The management of ACS during pregnancy via PCI in Pakistani hospitals reveals significant in-hospital outcomes. The high incidence of MACE and other complications underscores the need for specialized care and monitoring for pregnant women undergoing PCI. These findings provide valuable insights for clinicians and highlight the necessity for further research to develop standardized protocols and improve clinical outcomes in this unique patient population.
References
2. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. J Am Coll Cardiol. 2011;58(24).
3. Mehta LS, Warnes CA, Bradley E, et al. Cardiovascular considerations in caring for pregnant patients: A scientific statement from the American Heart Association. Circulation. 2020;141(23).
4. Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, et al. Is a planned caesarean section necessary in women with cardiac disease? Heart. 2015;101(6):530-6.
5. Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan: women and men at equal risk. Am Heart J. 2005;150(2):221-6.
6. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34):3165-241.
7. Ruys TPE, Cornette JMJ, Roos-Hesselink JW, et al. Pregnancy and delivery in cardiac disease: a multidisciplinary approach. Best Pract Res Clin Obstet Gynaecol. 2014;28(4):483-95.
8. Karamlou T, Diggs BS, McCrindle BW, et al. Pregnancy outcomes in women with congenital heart disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2007;49(24):2303-11.
9. Elkayam U, Goland S, Pieper PG, et al. High-Risk Cardiac Disease in Pregnancy. J Am Coll Cardiol. 2016;68(5):502-16.
10. Bedard E, Dimopoulos K, Gatzoulis MA. Pregnancy in women with congenital heart disease. Heart. 2008;94(10):1250-5.
11. Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21.
12. Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92(10):1520-5.
13. Pijuan-Domènech A, Galian L, Ferrero S, et al. Cardiac complications during pregnancy in women with Marfan syndrome. Int J Cardiol. 2010;145(3):702-5.
14. Silversides CK, Colman JM, Sermer M, et al. Cardiac risk in pregnant women with rheumatic mitral stenosis. Am J Cardiol. 2003;91(11):1382-5.
15. Tutarel O, Baris L, Budts W, et al. Pregnancy and delivery in women with cardiovascular conditions: General considerations. Int J Cardiol. 2015;187:133-9.